載入...
Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation
INTRODUCTION: In this study, we evaluated the clinical relevance of serum drug levels and antidrug antibodies (ADAbs) with regard to response to treatment, as well as to relapse upon treatment discontinuation, in peripheral spondyloarthritis (pSpA) patients treated with adalimumab. METHODS: The stud...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261980/ https://ncbi.nlm.nih.gov/pubmed/25074046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4675 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|